Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd., commonly referred to as Huahong Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in the Guangxi Zhuang Autonomous Region of China. Established in 1998, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Huahong Pharmaceutical is renowned for its innovative core products, which include herbal medicines and chemical drugs. The company’s commitment to quality and research has positioned it as a leader in the market, achieving notable certifications and accolades that underscore its dedication to excellence. As a trusted name in the pharmaceutical sector, Huahong continues to contribute to healthcare advancements both domestically and internationally.
How does Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd. currently does not have available carbon emissions data, as indicated by the absence of specific figures for kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. As a result, there are no specific commitments or initiatives to report regarding their carbon footprint or climate action strategies. The lack of emissions data and reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. In the broader context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set science-based targets to reduce their carbon emissions. However, without specific data or commitments from Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd., it is challenging to assess their position within this evolving landscape.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Guangxi Zhuangzu Autonomous Region Huahong Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.